Protracted periods of increased cortisol production, as may
be seen in acute illness, may lead to transient hyperglycemia. Increasing
evidence suggests that cortisol may then mediate insulin resistance and
potentially lead to the development of diabetes. Evidence in animal studies
also suggests that under conditions of stress Ginkgo biloba extract could
reduce plasma cortisol production and so the primary aim of this study was to
determine the effect of Ginkgo biloba extract ingestion on plasma cortisol
production during an acute period of glucose challenge. Healthy normal glucose
tolerant subjects (n=30, (10/20, M/F); age, 45.79.9 years
old) completed a randomized, double-blind, placebo-controlled crossover study
when they ingested Ginkgo biloba extract (120 mg/day as a single dose) or placebo
during each 3-month arm. A standard 75 g oral glucose tolerance test was
performed at the end of each cycle and blood was collected and used to measure
plasma glucose, insulin, c-peptide and cortisol. Fasting plasma cortisol was
significantly lower after the Ginkgo biloba cycle than the placebo cycle (9.74.4 vs. 11.85.4 g/dl, respectively; p<0.05). The plasma cortisol
area under the curve during the 2-hour test (AUC0-2) was also significantly
lower after ingestion of the Ginkgo biloba cycle compared to the placebo
(19.27.7 vs. 24.14.9 μg/dl/h, respectively;
p<0.001). It is concluded that the ingestion of Ginkgo biloba extract has
effect on the hypothalamic-pituitary-adrenal axis leading to reduced basal
cortisol levels and reduced cortisol production in response to acute
hyperglycemic challenge.
Author(s) Details
Dr. George B. KudoloAuthor(s) Details
Department of Health Sciences, Division of Medical Laboratory Sciences, School of Health Professions, University of Texas Health Science Center at San Antonio, Texas, USA.
View Book :- http://bp.bookpi.org/index.php/bpi/catalog/book/203
No comments:
Post a Comment